• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Biodesix, Inc. - Common Stock (NQ:BDSX)

    25.63 -0.79 (-2.99%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 95,952
    Open 26.24
    Bid (Size) 25.35 (300)
    Ask (Size) 25.66 (100)
    Prev. Close 26.42
    Today's Range 25.10 - 26.50
    52wk Range 5.260 - 31.97
    Shares Outstanding 78,614,114
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
    Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise 
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
    Industry-leading QA/RA excellence accelerates patient access to Biodesix Lab testing, which helps improve overall outcomes for patients with lung nodules 
    From Biodesix, Inc.
    Via GlobeNewswire

    Performance

    52-Week Range 19.8% below 52-week high
    25.63
    5.2652W Low 31.9752W High
    1 Week 14.6% below 1-week high
    26.071W Low 30.001W High

    Biodesix, Inc. - Common Stock (BDSX) traded between $5.26 and $31.97 over the past 52 weeks and last traded at $25.63, 19.8% below its 52-week high. Over the past week it ranged between $26.07 and $30.00.

    Past 12 Months
    -6.2%
    -3.8%
    +27.2%
    +79.9%
    +296.7%
    +251.1%
    1W -$1.70
    1M -$1.00
    3M +$5.48
    6M +$11.38
    YTD +$19.17
    1Y +$18.33

    BDSX was +251.1% over the past year, +79.9% over six months, +296.7% year to date, -6.2% in the last week.

    12 Months vs Market
    BDSX
    +251.1%
    DIA
    +9.8%
    SPY
    +15.7%
    QQQ
    +23.7%
    IWM
    +13.7%

    Over the past 12 months BDSX returned +251.1% versus DIA (Dow) +9.8%, SPY (S&P 500) +15.7%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +13.7%.

    Volume & Liquidity 0.95× 3-mo avg
    Today 95,952 3-mo avg 100.9K
    1W
    128.8K
    1M
    101.2K
    3M
    100.9K
    6M
    87.8K
    YTD
    525.4K
    1Y
    434.9K

    BDSX most recently traded 95,952 shares against a 3-month average daily volume of 100.9K.

    More News

    Read More
    News headline image
    Biodesix to Participate in Upcoming Investor Conferences
    From Biodesix, Inc.
    Via GlobeNewswire
    BioDesix (NASDAQ:BDSX) Passes Minervini Trend Template but Setup Quality Remains Weak ↗
    Via Chartmill
    Biodesix (NASDAQ:BDSX) Q2 EPS Beats, Revenue In Line, Shares Slip ↗
    Via Chartmill
    Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance ↗
    Via Chartmill
    Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Biodesix (BDSX) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference ↗
    Via MarketBeat
    News headline image
    Biodesix Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Biodesix Announces Second Quarter 2026 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Participate in Upcoming Investor Conferences
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix (BDSX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Biodesix BDSX Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Biodesix Announces First Quarter 2026 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Recognized as a Top Workplace for Third Consecutive Year
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix (BDSX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Participate in Upcoming Investor Conferences
    From Biodesix, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Biodesix, Inc. - Common Stock publicly traded?
    Yes, Biodesix, Inc. - Common Stock is publicly traded.
    What exchange does Biodesix, Inc. - Common Stock trade on?
    Biodesix, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Biodesix, Inc. - Common Stock?
    The ticker symbol for Biodesix, Inc. - Common Stock is BDSX on the Nasdaq Stock Market
    What is the current price of Biodesix, Inc. - Common Stock?
    The current price of Biodesix, Inc. - Common Stock is 25.63
    When was Biodesix, Inc. - Common Stock last traded?
    The last trade of Biodesix, Inc. - Common Stock was at 10/08/26 04:00 PM ET
    What is the market capitalization of Biodesix, Inc. - Common Stock?
    The market capitalization of Biodesix, Inc. - Common Stock is 2.01B
    How many shares of Biodesix, Inc. - Common Stock are outstanding?
    Biodesix, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.